Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENXBIO Inc. | 39,815 | reported | 30 May 2025 | tx 8+133,964 |
| Merck & Co., Inc. | 35,312 | reported | 05 May 2026 | tx 51+1,047,383−821,133 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 12,064 | 0.00 USD | deriv |
| 05 May 2026 | GRANT_AWARD | Merck & Co., Inc. | 35,312 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 38,835 | 119.15 USD | |
| 09 Feb 2026 | SALE | Merck & Co., Inc. | 38,835 | 119.15 USD | |
| 09 Feb 2026 | SALE | Merck & Co., Inc. | 56,792 | 119.15 USD | |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 25,946 | 119.15 USD | |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 56,792 | 119.15 USD | |
| 09 Feb 2026 | SALE | Merck & Co., Inc. | 25,946 | 119.15 USD | |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 25,946 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 56,792 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Merck & Co., Inc. | 38,835 | 0.00 USD | deriv |
| 26 Jan 2026 | GRANT_AWARD | Merck & Co., Inc. | 11,583 | 107.40 USD | |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 7,768 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 39,815 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 8,854 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Merck & Co., Inc. | 40,301 | 0.00 USD | deriv |
| 27 Jan 2025 | GRANT_AWARD | Merck & Co., Inc. | 25,423 | 97.94 USD | |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 4,790 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 24,454 | 0.00 USD | deriv |
| 30 Apr 2024 | GRANT_AWARD | Merck & Co., Inc. | 35,156 | 0.00 USD | deriv |
| 02 Feb 2024 | SALE | Merck & Co., Inc. | 49,499 | 126.97 USD | |
| 02 Feb 2024 | EXERCISE | Merck & Co., Inc. | 19,417 | 87.10 USD | |
| 02 Feb 2024 | EXERCISE | Merck & Co., Inc. | 19,417 | 0.00 USD | deriv |
| 22 Jan 2024 | GRANT_AWARD | Merck & Co., Inc. | 23,298 | 119.43 USD | |
| 02 Jun 2023 | GRANT_AWARD | REGENXBIO Inc. | 3,486 | 0.00 USD |